BE's PNEUBEVAX 14® receives WHO pre-qualification, strengthening Global pneumococcal vaccine access
Nov 20, 2025
Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company, announced on Thursday that its 14-valent Pneumococcal Conjugate Vaccine (PCV), PNEUBEVAX 14® (BE-PCV-14), has...